Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(11 sites)
United States
Paradigm Clinical Research, La Mesa, California Paradigm Clinical Research - Modesto, Modesto, California Velocity Clinical Research, Boise, Meridian, Idaho Clinical Research Prime, Rexburg, Idaho AMR Newton, Newton, Kansas Velocity Clinical Research - Lafayette, Lafayette, Louisiana Velocity Clinical Research, Grand Island, Grand Island, Nebraska Velocity Clinical Research, Cleveland, Beachwood, Ohio Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio Velocity Clinical Research, Austin, Cedar Park, Texas Baylor College of Medicine, Houston, Texas